Open AccessChemotherapy versus alectinib for the treatment of crizotinib-pretreated ALK-positive patients with non small cell lung cancer
Author(s) -
Ting Gao,
Chenxi Li,
Xiaopeng He,
Tao Zhang
Publication year - 2022
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000029064
Subject(s) - alectinib , crizotinib , medicine , anaplastic lymphoma kinase , lung cancer , oncology , chemotherapy , cochrane library , adverse effect , meta analysis , clinical trial , malignant pleural effusion